Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125046663 | 12504666 | 3 | F | 20160907 | 20160628 | 20160922 | PER | US-ELI_LILLY_AND_COMPANY-US201606005883 | ELI LILLY AND CO | 53.00 | YR | F | Y | 66.00000 | KG | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125046663 | 12504666 | 1 | PS | ADCIRCA | TADALAFIL | 1 | Unknown | 20 (UNIT UNSPECIFIED), UNKNOWN | U | U | 21368 | TABLET | |||||||
| 125046663 | 12504666 | 2 | SS | LETAIRIS | AMBRISENTAN | 1 | Unknown | 5 MG, QD | 1412805A | 0 | 5 | MG | QD | ||||||
| 125046663 | 12504666 | 3 | SS | LETAIRIS | AMBRISENTAN | 1 | Unknown | 10 MG, QD | 1509507A | 0 | 10 | MG | QD | ||||||
| 125046663 | 12504666 | 4 | C | ADEMPAS | RIOCIGUAT | 1 | Unknown | UNK, UNKNOWN | U | U | 0 | ||||||||
| 125046663 | 12504666 | 5 | C | ATORVASTATIN | ATORVASTATIN | 1 | 0 | ||||||||||||
| 125046663 | 12504666 | 6 | C | VOLTAREN | DICLOFENAC SODIUM | 1 | 0 | ||||||||||||
| 125046663 | 12504666 | 7 | C | FENOFIBRATE. | FENOFIBRATE | 1 | 0 | ||||||||||||
| 125046663 | 12504666 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125046663 | 12504666 | 1 | Pulmonary hypertension |
| 125046663 | 12504666 | 2 | Pulmonary arterial hypertension |
| 125046663 | 12504666 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125046663 | 12504666 | Headache | |
| 125046663 | 12504666 | Hypersensitivity | |
| 125046663 | 12504666 | Nasal congestion | |
| 125046663 | 12504666 | Nasopharyngitis | |
| 125046663 | 12504666 | Rhinorrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125046663 | 12504666 | 1 | 20160606 | 0 | ||
| 125046663 | 12504666 | 2 | 20160524 | 0 |